GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
507
c/compounding·posted 3 months ago by u/santiago_rasmussen

small win: compounding stopped being a problem at week 40

Explainer Clean Column ×5

Something I noticed reading old threads that I have not seen said out loud.

The advice on shortage list in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.

I have listed what I think the current consensus is below. Correct me — that is the point of posting it.

683 up / 176 down80% upvoted21 commentsid k0x7a121 Apr 2026

21 comments

20 in this archive, depth 4

best — the order this archive was captured in

u/ignacio_vanhecke62 points·3 months ago·edited

What is the actual shortage list status right now?

replysharereportpermalink
u/prior_auth_painappeals60 points·3 months ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/santiago_rasmussenOP43 points·3 months ago

The telehealth + compounding combo cost telehealth plus 8% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/escrow_evangelist34 points·3 months ago·edited

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
load more comments (1) →
u/nadia_fonseca42 points·3 months ago·edited
controversial sort brought me here and it was worth it
replysharereportpermalink
u/food_noise_gonemaintenance27 points·3 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/maren_sorensen18 points·3 months ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/incretin_ivypharmacology23 points·3 months ago

no pharmacy referral codes, naming is fine, recruiting is not

Adding to this: 503B is doing more work than the comment implies.

replysharereportpermalink
u/mikkel_correia17 points·3 months ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/santiago_rasmussenOP16 points·3 months ago

Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.

replysharereportpermalink
u/milos_mensa13 points·3 months ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/gustav_cardoso12 points·3 months ago

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

replysharereportpermalink
u/controversial_only7 points·3 months ago

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

replysharereportpermalink
u/stubborn_batchlist_pls4 points·3 months ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/dario_stanescu6 points·3 months ago

Are we talking 503A or 503B?

replysharereportpermalink
u/santiago_rasmussenOP4 points·3 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
load more comments (1) →
u/elin_ferrari3 points·3 months ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/marit_laurent-13 points·3 months ago

What is the actual shortage list status right now?

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →